Variable | All Patients | Dislocation (n = 1,258) | p |
---|---|---|---|
n, (%) | 275,107 (100.0) | 1,258 (0.5) | – |
Demographics | |||
 Sex, n (%) | 0.004 | ||
  Male | 123,829 (45.0) | 507 (40.3) |  |
  Female | 151,194 (55.0) | 750 (59.7) |  |
  Non-Binary | 4 (0.0) | 0 (0.0) |  |
 Race, n (%) |  < 0.001 | ||
  White | 200,305 (72.9) | 978 (77.9) |  |
  Black/African American | 21,242 (7.7) | 102 (8.1) |  |
  Asian | 4,099 (1.5) | 31 (2.5) |  |
  Native Hawaiian/Pacific Islander | 651 (0.2) | 2 (0.2) |  |
  American Indian/Alaska Native | 1,090 (0.4) | 11 (0.9) |  |
  Unknown/Not Reported | 47,454 (17.3) | 131 (10.4) |  |
  Other Race | 32 (0.0) | 0 (0.0) |  |
  Race Combinations with Low Frequency | 1 (0.0) | 0 (0.0) |  |
 Ethnicity, n (%) | 0.001 | ||
  Non-Hispanic | 216,932 (96.2) | 1,058 (94.3) |  |
  Hispanic | 8,632 (3.8) | 64 (5.7) |  |
  Age, mean ± SD | 65.4 ± 11.4 | 68.1 ± 13.3 |  < 0.001 |
  Height, mean ± SD | 66.2 ± 4.2 | 65.5 ± 4.3 |  < 0.001 |
  Weight, mean ± SD | 188.7 ± 46.0 | 177.6 ± 48.4 |  < 0.001 |
  BMI, mean ± SD | 30.2 ± 6.3 | 28.9 ± 6.8 |  < 0.001 |
 BMI Categories |  < 0.001 | ||
  BMI < 18.5 | 2,429 (0.9) | 42 (3.4) |  |
  18.5–24.9 | 52,023 (19.1) | 337 (27.1) |  |
  25–29.9 | 91,011 (33.3) | 372 (30.0) |  |
  30–39.9 | 108,163 (39.6) | 421 (33.9) |  |
  > 40 | 19,458 (7.1) | 70 (5.6) |  |
Preoperative Laboratory Values | |||
 eGFR Levels, n (%) |  < 0.001 | ||
  Normal | 93,162 (36.2) | 425 (36.3) |  |
  Mild/Moderate | 162,008 (63.0) | 718 (61.4) |  |
  Severe | 2,121 (0.8) | 27 (2.3) |  |
 Sodium Levels, n (%) |  < 0.001 | ||
  Low | 12,214 (4.8) | 109 (9.2) |  |
  Normal | 242,366 (95.1) | 1,067 (90.5) |  |
  High | 352 (0.1) | 3 (0.3) |  |
  BUN, mean ± SD | 17.9 ± 7.3 | 18.5 ± 8.6 | 0.011 |
  Serum Creatinine, mean ± SD | 0.9 ± 0.4 | 1.0 ± 0.6 | 0.022 |
 BUN/Cr Level, n (%) | 0.039 | ||
  < 20 | 125,362 (52.7) | 581 (51.1) |  |
  20–25 | 62,776 (26.4) | 283 (24.9) |  |
  25 +  | 49,952 (21.0) | 273 (24.0) |  |
  BUN/Cr > 10, n (%) | 112,728 (47.3) | 556 (48.9) | 0.293 |
  Hypoalbuminemia, n (%) | 7,580 (5.3) | 148 (21.0) |  < 0.001 |
  Total Bilirubin, mean ± SD | 0.6 ± 0.4 | 0.6 ± 0.5 | 0.420 |
  SGOT, mean ± SD | 24.0 ± 15.8 | 24.1 ± 14.4 | 0.962 |
 Alkaline Phosphatase Levels, n (%) |  < 0.001 | ||
  < 44 | 3,670 (2.8) | 18 (2.8) |  |
  44–147 | 123,068 (94.6) | 576 (89.3) |  |
  148 +  | 3,377 (2.6) | 51 (7.9) |  |
 WBC Level, n (%) |  < 0.001 | ||
  Low/Normal | 253,832 (97.3) | 1,143 (95.4) |  |
  High | 6,929 (2.7) | 55 (4.6) |  |
 Anemia Severity, n (%) |  < 0.001 | ||
  Non-Anemia | 225,007 (85.8) | 758 (62.9) |  |
  Mild Anemia | 28,657 (10.9) | 265 (22.0) |  |
  Moderate/Severe Anemia | 8,595 (3.3) | 182 (15.1) |  |
  Low Platelet, n (%) | 7,855 (3.0) | 46 (3.8) | 0.095 |
  PTT, mean ± SD | 29.4 ± 5.0 | 29.7 ± 6.3 | 0.247 |
  INR, mean ± SD | 1.0 ± 0.3 | 1.1 ± 0.3 |  < 0.001 |
  PT, mean ± SD | 11.9 ± 2.5 | 12.1 ± 1.7 |  |
Past Medical History | |||
 Diabetes, n (%) |  < 0.001 | ||
  Not Diabetic | 241,555 (87.8) | 1,058 (84.1) |  |
  Insulin Dependent | 8,063 (2.9) | 70 (5.6) |  |
  Non-Insulin Dependent | 25,116 (9.1) | 126 (10.0) |  |
  Oral Medication | 373 (0.1) | 4 (0.3) |  |
 Smoking Status, n (%) | 0.006 | ||
  Non-Smoker | 240,774 (87.5) | 1,069 (85.0) |  |
  Smoker | 34,333 (12.5) | 189 (15.0) |  |
 Dyspnea, n (%) | 0.011 | ||
  None | 262,265 (95.3) | 1,178 (93.6) |  |
  At Rest | 546 (0.2) | 2 (0.2) |  |
  Moderate Exertion | 12,296 (4.5) | 78 (6.2) |  |
  History of Severe COPD, n (%) | 10,897 (4.0) | 99 (7.9) |  < 0.001 |
  Ascites, n (%) | 73 (0.0) | 0 (0.0) | 1.000 |
  CHF (in 30 days before surgery), n (%) | 1,108 (0.4) | 11 (0.9) | 0.021 |
  Hypertension Requiring Medication, n (%) | 152,514 (55.4) | 761 (60.5) |  < 0.001 |
  Renal Failure, n (%) | 186 (0.1) | 2 (0.2) | 0.209 |
  Currently on Dialysis (Preop), n (%) | 697 (0.3) | 14 (1.1) |  < 0.001 |
  Disseminated Cancer, n (%) | 1,170 (0.4) | 9 (0.7) | 0.122 |
  Steroid Use for Chronic Condition, n (%) | 10,225 (3.7) | 54 (4.3) | 0.263 |
  > 10% Loss Body Weight in Last 6 Months, n (%) | 683 (0.2) | 11 (0.9) |  < 0.001 |
  Bleeding Disorders, n (%) | 6,221 (2.3) | 52 (4.1) |  < 0.001 |
  Transfusion > 4 Units PRBCs in 72 Hours Before Surgery, n (%) | 481 (0.2) | 17 (1.4) |  < 0.001 |
 Preoperative Systemic Sepsis, n (%) |  < 0.001 | ||
  None | 273,344 (99.4) | 1,230 (98.0) |  |
  SIRS | 1,526 (0.6) | 7 (0.6) |  |
  Sepsis | 95 (0.0) | 15 (1.2) |  |
  Septic Shock | 10 (0.0) | 3 (0.2) |  |
 Frailty, n (%) |  < 0.001 | ||
  < 2 | 236,317 978 (77.7) | 978 (86.3) |  |
  ≥ 2 | 37,532 (22.3) | 280 (13.7) |  |
Operative Details | |||
 Location, n (%) |  < 0.001 | ||
  Outpatient | 18,000 (6.5) | 34 (2.7) |  |
  Inpatient | 257,107 (93.5) | 1224 (97.3) |  |
 Anesthesia, n (%) |  < 0.001 | ||
  Epidural | 1,656 (0.6) | 12 (1.0) |  |
  General | 130,519 (47.4) | 870 (69.2) |  |
  Local | 65 (0.0) | 0 (0.0) |  |
  None | 40 (0.0) | 0 (0.0) |  |
  Other | 147 (0.1) | 2 (0.2) |  |
  Regional | 5,186 (1.9) | 15 (1.2) |  |
  Spinal | 99,084 (36.0) | 268 (21.3) |  |
  MAC/IV Sedation | 38,360 (13.9) | 91 (7.2) |  |
  Unknown | 35 (0.0) | 0 (0.0) |  |
 ASA Class, n (%) | |||
  0 = None Assigned | 24 (0.0) | 0 (0.0) |  |
  1 = No Disturb | 9,859 (3.6) | 23 (1.8) |  |
  2 = Mild Disturb | 142,500 (51.8) | 438 (34.8) |  |
  3 = Severe Disturb | 116,506 (42.4) | 716 (56.9) |  |
  4 = Life Threat | 5,925 (2.2) | 81 (6.4) |  |
  5 = Moribund | 21 (0.0) | 0 (0.0) |  |
  Operative Time, mean ± SD | 91.9 ± 39.1 | 137.4 ± 71.1 |  < 0.001 |